Ramona Doyle Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Ramona Doyle is Chief Medical Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 121,110 shares of RXRX, which is worth approximately $690,327. The most recent transaction as insider was on May 16, 2022, when has been sold 832 shares (Class A Common Stock) at a price of $5.67 per share, resulting in proceeds of $4,717. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K

0% 3M change

0% 12M change

Total Value Held $690,327

Ramona Doyle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	SELL Payment of exercise price or tax liability	$4,717 $5.67 p/Share	832 Reduced 0.68%	121,110 Class A Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	$22,499 $2.48 p/Share	9,072 Added 6.92%	121,942 Class A Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	$38,750 $2.48 p/Share	15,625 Added 12.16%	112,870 Class A Common Stock
Feb 04 2022	SELL Payment of exercise price or tax liability	$11,183 $11.4 p/Share	981 Reduced 1.0%	97,245 Class A Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	-	40,891 Added 29.39%	98,226 Class A Common Stock
Jan 31 2022	BUY Exercise of conversion of derivative security	$38,750 $2.48 p/Share	15,625 Added 21.42%	57,335 Class A Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$99,595 $2.47 p/Share	40,322 Added 50.0%	40,322 Class A Common Stock

Ramona Doyle

Chief Medical Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account